After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal ...

Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

With the backing of Rishi Sunak, Prostate Cancer UK published a report to the national screening committee back in 2022 in ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Channing Paller discussing germline and somatic genetic ...

How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

Doctors can order genetic tests for people at high risk of breast cancer, and insurance often covers those, Kamal says. For ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

In honor of Breast Cancer Awareness Month, the TODAY show, with the help of breast cancer survivors Jill Martin and Sheryl ...

By Stephen Beech Men with advanced prostate cancer have been offered fresh hope thanks to a "promising" new drug combination.